Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer

PURPOSE: Androgen deprivation therapy may increase diabetes risk. As the benefits of primary androgen deprivation therapy for localized prostate cancer are controversial, and most prostate cancer survivors are of advanced age with comorbidities, it is important to determine if primary androgen depri...

Full description

Saved in:
Bibliographic Details
Published in:J Urol
Main Authors: Tsai, Huei-Ting, Keating, Nancy L., Van Den Eeden, Stephen K., Haque, Reina, Cassidy-Bushrow, Andrea E., Yood, Marianne Ulcickas, Smith, Matthew R., Potosky, Arnold L.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4543371/
https://ncbi.nlm.nih.gov/pubmed/25524243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.12.027
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items